01801.HK Relative Valuation
01801.HK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, 01801.HK is overvalued; if below, it's undervalued.
Historical Valuation
INNOVENT BIO (01801.HK) is now in the Fair zone, suggesting that its current forward PS ratio of 9.41 is considered Fairly compared with the five-year average of 74.98. The fair price of INNOVENT BIO (01801.HK) is between 35.84 to 121.52 according to relative valuation methord.
Relative Value
Fair Zone
35.84-121.52
Current Price：90.90
Fair
59.33
PE
1Y
3Y
5Y
Trailing
Forward
70.44
EV/EBITDA
INNOVENT BIO. (01801.HK) has a current EV/EBITDA of 70.44. The 5-year average EV/EBITDA is -43.18. The thresholds are as follows: Strongly Undervalued below -374.96, Undervalued between -374.96 and -209.07, Fairly Valued between 122.71 and -209.07, Overvalued between 122.71 and 288.59, and Strongly Overvalued above 288.59. The current Forward EV/EBITDA of 70.44 falls within the Historic Trend Line -Fairly Valued range.
66.06
EV/EBIT
INNOVENT BIO. (01801.HK) has a current EV/EBIT of 66.06. The 5-year average EV/EBIT is -9.65. The thresholds are as follows: Strongly Undervalued below -267.06, Undervalued between -267.06 and -138.36, Fairly Valued between 119.06 and -138.36, Overvalued between 119.06 and 247.76, and Strongly Overvalued above 247.76. The current Forward EV/EBIT of 66.06 falls within the Historic Trend Line -Fairly Valued range.
9.41
PS
INNOVENT BIO. (01801.HK) has a current PS of 9.41. The 5-year average PS is 10.18. The thresholds are as follows: Strongly Undervalued below -0.91, Undervalued between -0.91 and 4.64, Fairly Valued between 15.73 and 4.64, Overvalued between 15.73 and 21.27, and Strongly Overvalued above 21.27. The current Forward PS of 9.41 falls within the Historic Trend Line -Fairly Valued range.
46.19
P/OCF
INNOVENT BIO. (01801.HK) has a current P/OCF of 46.19. The 5-year average P/OCF is -46.64. The thresholds are as follows: Strongly Undervalued below -406.72, Undervalued between -406.72 and -226.68, Fairly Valued between 133.40 and -226.68, Overvalued between 133.40 and 313.44, and Strongly Overvalued above 313.44. The current Forward P/OCF of 46.19 falls within the Historic Trend Line -Fairly Valued range.
101.46
P/FCF
INNOVENT BIO. (01801.HK) has a current P/FCF of 101.46. The 5-year average P/FCF is 1498.25. The thresholds are as follows: Strongly Undervalued below -7337.27, Undervalued between -7337.27 and -2919.51, Fairly Valued between 5916.01 and -2919.51, Overvalued between 5916.01 and 10333.77, and Strongly Overvalued above 10333.77. The current Forward P/FCF of 101.46 falls within the Historic Trend Line -Fairly Valued range.
INNOVENT BIO (01801.HK) has a current Price-to-Book (P/B) ratio of 9.73. Compared to its 3-year average P/B ratio of 5.65 , the current P/B ratio is approximately 72.24% higher. Relative to its 5-year average P/B ratio of 6.02, the current P/B ratio is about 61.81% higher. INNOVENT BIO (01801.HK) has a Forward Free Cash Flow (FCF) yield of approximately 1.01%. Compared to its 3-year average FCF yield of -2.01%, the current FCF yield is approximately -150.34% lower. Relative to its 5-year average FCF yield of -3.04% , the current FCF yield is about -133.34% lower.
9.73
P/B
Median3y
5.65
Median5y
6.02
1.01
FCF Yield
Median3y
-2.01
Median5y
-3.04
Performance Decomposition
1Y
3Y
5Y
Market capitalization of 01801.HK increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 01801.HK in the past 1 year is driven by Unknown.
People Also Watch
FAQ
Is INNOVENT BIO (01801.HK) currently overvalued or undervalued?
What is INNOVENT BIO (01801.HK) fair value?
How does 01801.HK's valuation metrics compare to the industry average?
What is the current P/B ratio for INNOVENT BIO (01801.HK) as of Dec 05 2025?
What is the current FCF Yield for INNOVENT BIO (01801.HK) as of Dec 05 2025?
What is the current Forward P/E ratio for INNOVENT BIO (01801.HK) as of Dec 05 2025?